ApoJ plays an important role as an essential determinant of CSF cholesterol efflux capacity; ApoJ mitigates the risk of mild cognitive injury and AD via the cellular efflux of cholesterol or other lipids [159]. This evidence concerns the gene CLU and Alzheimer disease.